Sath Shukla - CEO & President at Spero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President
Issuer Symbol
SPRO on Nasdaq
All Insider Reports
All Insider Reports

Sath Shukla - trading volume in the past year for Spero Therapeutics, Inc.

Holdings reported by Sath Shukla for Spero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,736,883 $1,354,769 $0.7800 05 Feb 2025 Direct

Transactions reported by Sath Shukla for Spero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.